Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China · Delayed Price · Currency is CNY 20.27
+0.09 (0.45%)
Aug 4, 2026, 3:04 PM CST
SHE:002880 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,264 | 1,267 | 1,203 | 1,049 | 667.93 | 907.43 |
Revenue Growth | 5.13% | 5.27% | 14.75% | 56.98% | -26.39% | 0.32% |
Gross Profit Gross Profit Growth | 489.83 | 498.61 | 503.87 | 433.24 | 240.91 | 370.91 |
Operating Income Operating Income Growth | 275.45 | 290.15 | 323.76 | 241.93 | 116.44 | 226.4 |
Net Income Net Income Growth | 233.54 | 246.32 | 253.52 | 218.65 | 117.52 | 205.44 |
Earnings Per Share EPS Growth | 1.03 | 1.09 | 1.12 | 0.96 | 0.52 | 0.91 |
EPS Growth | -6.76% | -2.84% | 15.94% | 86.05% | -42.79% | 7.90% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Blood Products Blood Products Growth | 1,108 | 1,072 | 985.02 | 653.93 | 889.29 |
Property Lease Property Lease Growth | 141.56 | 120.97 | 34.52 | - | - |
Unallocated Other Industry Unallocated Other Industry Growth | 16.66 | 10.54 | 28.96 | - | 18.14 |
Total Total Growth | 1,267 | 1,203 | 1,049 | 667.93 | 907.43 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 76.63 | 369.81 | 428.08 | 273.77 | 294.59 | 332.1 |
Total Debt Total Debt Growth | 813.62 | 850.29 | 697.28 | 536.46 | 547.02 | 43.42 |
Net Cash (Debt) Net Cash Growth | -737 | -480.47 | -269.21 | -262.69 | -252.44 | 288.68 |
Net Cash Growth | - | - | - | - | - | -25.90% |
Net Cash Per Share Net Cash Per Share Growth | -3.25 | -2.12 | -1.19 | -1.16 | -1.11 | 1.27 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 124.36 | 263.18 | 177.77 | 397.94 | 1.2 | 246.89 |
Capital Expenditures CapEx Growth | -164.28 | -169.69 | -255.5 | -328.85 | -327.37 | -240.83 |
Free Cash Flow Free Cash Flow Growth | -39.92 | 93.49 | -77.73 | 69.08 | -326.17 | 6.06 |
Free Cash Flow Growth | - | - | - | - | - | -94.72% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 38.77% | 39.36% | 41.88% | 41.32% | 36.07% | 40.88% |
Operating Margin | 21.80% | 22.91% | 26.91% | 23.07% | 17.43% | 24.95% |
Pretax Margin | 21.30% | 22.34% | 24.66% | 23.41% | 20.56% | 26.58% |
Profit Margin | 18.48% | 19.45% | 21.07% | 20.85% | 17.59% | 22.64% |
FCF Margin | -3.16% | 7.38% | -6.46% | 6.59% | -48.83% | 0.67% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.200 | 0.200 | 0.400 | - | 0.200 |
Dividend Per Share Growth | 0% | 0% | -50.00% | - | - | 11.98% |
Dividend Yield | 1.00% | 0.79% | 0.75% | 1.16% | - | 0.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 19.60 | 23.48 | 24.16 | 36.44 | 61.55 | 35.53 |
Forward PE | 23.47 | 19.07 | 22.23 | 31.51 | 13.16 | 18.82 |
P/FCF Ratio | - | 61.86 | - | 115.33 | - | 1204.41 |
PS Ratio | 3.62 | 4.57 | 5.09 | 7.60 | 10.83 | 8.04 |